» Authors » J P Vannier

J P Vannier

Explore the profile of J P Vannier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 133
Citations 951
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roux C, Tifratene K, Socie G, Galambrun C, Bertrand Y, Rialland F, et al.
Bone Marrow Transplant . 2017 Jan; 52(5):678-682. PMID: 28112748
Allogeneic hematopoietic stem cell transplantation (SCT) contributes to improved outcome in childhood acute leukemia (AL). However, therapeutic options are poorly defined in the case of post-transplantation relapse. We aimed to...
2.
Petit C, Gouel F, Dubus I, Heuclin C, Roget K, Vannier J
BMC Cancer . 2016 Sep; 16(1):746. PMID: 27658583
Background: Several studies show that bone marrow (BM) microenvironment and hypoxia condition can promote the survival of leukemic cells and induce resistance to anti-leukemic drugs. However, the molecular mechanism for...
3.
Filhon B, Dumesnil C, Van Dreden P, Schneider P, Vasse M, Vannier J
Thromb Res . 2014 Sep; 134(5):1164-6. PMID: 25204998
No abstract available.
4.
Dulong C, Fang Y, Gest C, Zhou M, Patte-Mensah C, Mensah-Nyagan A, et al.
Int J Oncol . 2013 Dec; 44(2):539-47. PMID: 24337141
Voltage-gated Na+ channels (VGSCs) are highly expressed in several types of carcinomas including breast, prostate and lung cancers as well as in mesothelioma and cervical cancers. Although the VGSCs activity...
5.
Paillard C, Rochette E, Lutz P, Bertrand Y, Michel G, Bordigoni P, et al.
Bone Marrow Transplant . 2013 Jun; 48(11):1401-8. PMID: 23749103
We report French prospective experience with reduced-intensity conditioning-allo-SCT in 46 patients (median age: 15.5 years, 4.8-20.2) presenting high-risk AL (n=11), Hodgkin's lymphoma (n=15) or solid tumors (n=20). Graft sources were...
6.
Schneider P, Dubus I, Gouel F, Legrand E, Vannier J, Vasse M
Adv Hematol . 2011 Nov; 2011:274628. PMID: 22110504
The role of angiogenesis in acute leukaemia has been discussed since the cloning of the gene of vascular endothelial growth factor (VEGF) from the acute myelogenous leukemia cell line (HL60)...
7.
Colin S, Guilmain W, Creoff E, Schneider C, Steverlynck C, Bongaerts M, et al.
Br J Cancer . 2011 Aug; 105(7):1002-11. PMID: 21863033
Background: Tetraspanins are transmembrane proteins known to contribute to angiogenesis. CD9 partner-1 (CD9P-1/EWI-F), a glycosylated type 1 transmembrane immunoglobulin, is a member of the tetraspanin web, but its role in...
8.
Buchbinder N, Dumesnil C, Pinquier D, Merle V, Filhon B, Schneider P, et al.
J Hosp Infect . 2011 Jul; 79(2):155-60. PMID: 21783276
Viral respiratory infections are potentially life-threatening among children treated for cancer. We report a nosocomial outbreak of six cases of pandemic influenza A/H1N1/2009 on a paediatric haematology and oncology ward....
9.
Guilmain W, Colin S, Legrand E, Vannier J, Steverlynck C, Bongaerts M, et al.
Br J Cancer . 2011 Jan; 104(3):496-504. PMID: 21206492
Background: Loss of CD9 expression has been correlated with a higher motility and metastatic potential of tumour cells originating from different organs. However, the mechanism underlying this loss is not...
10.
Vuillermet P, Cauliez B, Freger P, Vannier J, Pellerin A, Kuhn J
J Pediatr Endocrinol Metab . 2009 Feb; 21(12):1169-78. PMID: 19189691
Primary germ cell tumors (PGCT) of the central nervous system usually develop in the third ventricle area, and most frequently in the pineal region. The suprasellar region is the second...